Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 05 - 05 save search
InfuSystem Reports First Quarter 2022 Financial Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
STMH | $0.1 -88.3% 2.2K
|
Manufacturing
|
| O: 0.0%
H: 49.0%
C: 39.5%
results
Elevation Oncology Reports First Quarter 2022 Financial Results and Highlights Recent Company Progress
Published: 2022-05-05 (Crawled : 12:00) - prnewswire.com
ELEV | $3.79 -5.49% -5.8% 990K
|
Professional, Scientific, and T...
|
| O: -3.27%
H: 27.78%
C: 23.31%
results
StrikeForce Strengthens it’s Government Relations Capabilities with Ankura Consulting Group, LLC.
Published: 2022-05-05 (Crawled : 15:00) - globenewswire.com
SFOR | $0.0205 2.5%
|
Information
|
| O: -9.67%
H: 21.77%
C: 9.59%
Opthea Data for OPT-302 in Combination with Ranibizumab for Polypoidal Choroidal Vasculopathy (PCV) Presented at ARVO 2022
Published: 2022-05-05 (Crawled : 11:00) - biospace.com/
OPT | $3.4 0.29% 3.7K
|
Health Technology
|
| O: -0.78%
H: 9.06%
C: 9.06%
opt-302
Melco Announces Unaudited First Quarter 2022 Earnings
Published: 2022-05-05 (Crawled : 12:20) - globenewswire.com
MSC | $7.49 1.89% 0.0% 3.1K
|
Consumer Services
|
| O: -10.49%
H: 10.34%
C: 8.97%
MLCO | $6.155 -1.2% -1.22% 2.5M
|
Consumer Services
|
| O: 1.77%
H: 0.87%
C: -9.9%
Belite Bio Presented Interim Results of LBS-008 Phase 1b/2 Study in Adolescent STGD1 at ARVO Annual Meeting 2022
Published: 2022-05-05 (Crawled : 13:00) - biospace.com/
BLTE | $33.49 -3.21% -3.31% 21K
|
n/a
|
| O: 6.14%
H: 12.0%
C: 8.5%
lbs-008 results phase 2b
Addex Reports Q1 2022 Financial Results
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
ADXN | News | $19.0 -9.35% -10.32% 20K
|
Health Technology
|
| O: 0.78%
H: 9.31%
C: 7.1%
results
mPhase Announces First Auto Dealer EV Charging Contract – to Provide Level 3 Chargers to Ford Dealership in Pennsylvania
Published: 2022-05-05 (Crawled : 14:00) - globenewswire.com
XDSL | $0.0015 2800.0% 5.3K
|
Manufacturing
|
| O: 5.5%
H: 16.11%
C: 6.64%
ford contract charging
The Severe Hypertriglyceridemia Market is Expected to Increase with a CAGR of 8.1% During the Study Period (2019-32) | DelveInsight
Published: 2022-05-05 (Crawled : 16:00) - prnewswire.com
JNJ | News | $147.91 1.49% -0.03% 9.6M
|
Health Technology
|
| O: 0.72%
H: 0.0%
C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M
|
Health Technology
|
| O: -0.36%
H: 0.0%
C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M
|
Health Technology
|
| O: 3.73%
H: 0.09%
C: -3.98%
ARWR | $22.33 -1.24% -1.25% 960K
|
Health Technology
|
| O: -0.98%
H: 0.23%
C: -5.52%
ETNB | $9.08 2.25% 2.2% 1M
|
Health Technology
|
| O: -0.44%
H: 8.85%
C: 6.64%
expected market
MasTec Announces First Quarter 2022 Financial Results with Record Backlog and Updates Guidance for the Year
Published: 2022-05-05 (Crawled : 21:00) - prnewswire.com
MTZ | $84.42 1.17% -1.58% 680K
|
Industrial Services
|
| O: -2.54%
H: 8.35%
C: 6.18%
ChipMOS REPORTS FIRST QUARTER 2022 RESULTS
Published: 2022-05-05 (Crawled : 07:00) - prnewswire.com
IMOS | $27.8 -2.39% -2.45% 20K
|
Electronic Technology
|
| O: -0.32%
H: 7.79%
C: 5.8%
results
Cardinal Health Reports Third Quarter Fiscal 2022 Results
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
CAH | $108.19 2.07% 0.0% 1.5M
|
Distribution Services
|
| O: -6.9%
H: 7.56%
C: 5.14%
health results
EOG Resources Reports First Quarter 2022 Results; Adds Quantitative Guidance to Cash Return Framework and Declares $1.80 per Share Special Dividend
Published: 2022-05-05 (Crawled : 21:00) - prnewswire.com
EOG | $133.17 1.07% 0.0% 2.5M
|
Energy Minerals
|
| O: 2.01%
H: 5.12%
C: 5.02%
Ideal Power to Present at May 2022 Conferences
Published: 2022-05-05 (Crawled : 15:20) - globenewswire.com
IPWR | $6.99 -3.19% -3.29% 41K
|
Producer Manufacturing
|
| O: -0.68%
H: 4.88%
C: 4.88%
Lantern Pharma Management to Speak at Multiple Investor and Scientific Conferences in May 2022
Published: 2022-05-05 (Crawled : 12:00) - biospace.com/
LTRN | $5.42 -6.07% -6.46% 240K
|
Health Technology
|
| O: -2.11%
H: 4.96%
C: 4.79%
pharma management
Mirum Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-05 (Crawled : 12:20) - biospace.com/
MIRM | News | $23.83 1.1% 1.09% 340K
|
Health Technology
|
| O: 1.1%
H: 12.93%
C: 4.73%
results
argenx Announces Positive Phase 3 Data from ADVANCE Trial of VYVGART® (efgartigimod alfa-fcab) in Adults with Primary Immune Thrombocytopenia
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
ARGX | $360.11 0.47% 0.47% 330K
|
Health Technology
|
| O: 3.33%
H: 6.9%
C: 4.68%
vyvgart trial positive phase 3
argenx Reports First Quarter 2022 Financial Results and Provides Business Update
Published: 2022-05-05 (Crawled : 10:00) - biospace.com/
ARGX | $360.11 0.47% 0.47% 330K
|
Health Technology
|
| O: 3.33%
H: 6.9%
C: 4.68%
results
HubSpot Reports Q1 2022 Results
Published: 2022-05-05 (Crawled : 21:00) - prnewswire.com
HUBS M | $631.24 -2.82% 0.09% 800K
|
Technology Services
|
| O: -0.06%
H: 12.9%
C: 4.51%
results
Palisade Bio and Newsoara Receive NMPA Clearance to Commence Phase 3 Clinical Trial in China Evaluating LB1148 to Accelerate the Return of Bowel Function Following Abdominal Surgery
Published: 2022-05-05 (Crawled : 13:00) - biospace.com/
PALI | $4.735 -6.61% -7.07% 140K
|
Manufacturing
|
| O: -2.21%
H: 7.35%
C: 4.49%
lb1148 clearance trial china phase 3
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Your saved searches
Save your searches and get alerts when important news are released.